Protagonist Therapeutics, Inc (PTGX)

144.33 -3.46% (-5.17)

Over 1M: +5.6%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

140 150 160
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '23 — Revenue: 0 Q3 '23 — Operating Cash Flow: -26.6M Q3 '23 — Free Cash Flow: -27M Q3 '23 — Net Income: -34.1M Q4 '23 — Revenue: 60M Q4 '23 — Operating Cash Flow: 17M Q4 '23 — Free Cash Flow: 16.9M Q4 '23 — Net Income: 27.3M Q1 '24 — Revenue: 255M Q1 '24 — Operating Cash Flow: -27.4M Q1 '24 — Free Cash Flow: -27.7M Q1 '24 — Net Income: 207.3M Q2 '24 — Revenue: 4.2M Q2 '24 — Operating Cash Flow: 268.6M Q2 '24 — Free Cash Flow: 268.6M Q2 '24 — Net Income: -30.6M Q3 '24 — Revenue: 4.7M Q3 '24 — Operating Cash Flow: -27.9M Q3 '24 — Free Cash Flow: -28.6M Q3 '24 — Net Income: -33.2M Q4 '24 — Revenue: 170.6M Q4 '24 — Operating Cash Flow: -29.2M Q4 '24 — Free Cash Flow: -29.5M Q4 '24 — Net Income: 131.7M Q1 '25 — Revenue: 28.3M Q1 '25 — Operating Cash Flow: 125.4M Q1 '25 — Free Cash Flow: 124.8M Q1 '25 — Net Income: -11.7M Q2 '25 — Revenue: 5.5M Q2 '25 — Operating Cash Flow: -28.8M Q2 '25 — Free Cash Flow: -29.6M Q2 '25 — Net Income: -34.8M Q3 '25 — Revenue: 4.7M Q3 '25 — Operating Cash Flow: -1.9M Q3 '25 — Free Cash Flow: -2M Q3 '25 — Net Income: -39.3M Q4 '25 — Revenue: 7.4M Q4 '25 — Operating Cash Flow: -37M Q4 '25 — Free Cash Flow: -37.1M Q4 '25 — Net Income: -44.4M Q1 '26 — Revenue: 56.4M Q1 '26 — Operating Cash Flow: -48.9M Q1 '26 — Free Cash Flow: -49.2M Q1 '26 — Net Income: 3.8M Q2 '26 — Revenue: 213.5M Q2 '26 — Operating Cash Flow: 219.1M Q2 '26 — Free Cash Flow: 218.9M Q2 '26 — Net Income: 162.8M 0 70M 140M 210M 280M
Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

5.7
OE margin 29.9%
Oper. margin 21.6%
SBC / sales 18.5%
Accruals -5.5%
FCF margin 48.4%
OCF / EBIT 2.2×
OCF margin 48.6%
ROA 9.4%
ROCE 6.9%
ROE 9.9%
Gross margin —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO growth -15.2%
RPO / sales —
Segment HHI —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.7
Current ratio 21.7×
Interest cover —
ND/EBITDA —
Debt / Eq 0.0×
Debt payback 0.0 yr
Payout 0.0%
Quick ratio 21.7×
F-score 5.1 pts
Cash / Debt —
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

7.9
Sales/sh Y/Y +715.6%
Sales CAGR 4Y +13.9%
EBIT Y/Y +143.3%
EPS Y/Y +63.1%
Sales Q/Q +99.0%
Div. growth —
EBIT CAGR —
EPS CAGR 4Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.